Dogwood Therapeutics, Inc. Share Price

Dogwood Therapeutics, Inc. Share Price

NASDAQ: DWTX | Micro Cap
$1.24
+$0.03 (2.90%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Dogwood Therapeutics, Inc. Stock Performance

Open
$1.25
Prev. Close
$1.21
Circuit Range
N/A
Day Range
$1.25 - $1.28
Year Range
$1.08 - $7.02
Volume
280
Average Traded
$1.26

Dogwood Therapeutics, Inc. Share Price Today

As of 30 October 2026, Dogwood Therapeutics, Inc.'s share price is $1.24. The stock opened at $1.25, compared to its previous close of $1.21. During today's trading session, Dogwood Therapeutics, Inc.'s share price traded between $1.25 and $1.28, with an average price of $1.27. Over the past 52 weeks, the stock has recorded a high of $7.02 and a low of $1.08. In terms of performance, Dogwood Therapeutics, Inc.'s share price has declined by 12.06% over the last six months and is down 80.59% on a year-on-year basis.

Dogwood Therapeutics, Inc. Share Price Chart

Line chart of the Dogwood Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 1.21 to 1.28, ending at 1.24.
$1.25$1.28
L
Show Current Price
H

Dogwood Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$6.17M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.06
Revenue (TTM)
$0.00
Return On Equity (TTM)
-52.72%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
26.75%

Dogwood Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$15.74-$3.78-$4.99-$11.53
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A75.98%-32.01%-131.06%

Dogwood Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$12.86-$35.51
Net Profit MarginN/AN/A
Income ChangeN/A-176.13%

About Dogwood Therapeutics, Inc.

Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.

Dogwood Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.39
$1.28
-3.76%
Sep 2026
$2.65
$1.33
-44.12%
Aug 2026
$1.68
$2.38
+46.91%
Jul 2026
$1.57
$1.62
-1.82%
Jun 2026
$1.69
$1.65
-1.20%
May 2026
$1.49
$1.67
+18.44%
Apr 2026
$2.35
$1.41
-30.51%
Mar 2026
$2.92
$2.03
-27.15%
Feb 2026
$2.79
$2.79
-2.28%
Jan 2026
$4.17
$2.85
-31.49%
Dec 2025
$6.18
$4.16
-35.00%
Nov 2025
$6.04
$6.40
+0.16%

DWTX Share Price FAQs